SB

Samsara BioCapital Portfolio holdings

AUM $766M
1-Year Est. Return 329.84%
This Quarter Est. Return
1 Year Est. Return
+329.84%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$484M
AUM Growth
+$19.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
58
New
Increased
Reduced
Closed

Top Buys

1
+$70.8M
2
+$6.87M
3
+$3.67M
4
INZY
Inozyme Pharma
INZY
+$2.89M
5
CYPH
Cypherpunk Technologies Inc
CYPH
+$288K

Top Sells

1
+$2.95M
2
+$2.16M
3
+$1.47M
4
SWTX
SpringWorks Therapeutics
SWTX
+$578K
5
BCEL
Atreca, Inc. Class A Common Stock
BCEL
+$153K

Sector Composition

1 Healthcare 99.94%
2 Financials 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$181K 0.04%
20,000
52
$147K 0.03%
21,244
53
$114K 0.02%
78,131
54
$55.8K 0.01%
13,669
55
$16K ﹤0.01%
133,333
56
$10K ﹤0.01%
99,999
57
– –
-22,204
58
– –
-100,000
1 2
3